Exendin (9-39)
- Cat.Number : AS-24467
- Manufacturer Ref. :
-
Availability :
In stock
This truncated Exendin-4 peptide, Exendin (9-39) amide, is a potent Glucagon-Like Peptide 1 (GLP-1) receptor antagonist. Unlike the full length Exendin-4 (a GLP-1 agonist), Exendin (9-39) antagonizes GLP-1–stimulated insulin release after food intake. It is a competitive inhibitor of Exendin-3 and Exendin-4.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
CAS registry number |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)


Glucagon-Like Peptide 1, GLP-1 (7-36), amide, human, mouse, rat, bovine, guinea pig

Citations
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
Am J Physiol Gastrointest Liver Physiol . 2012 Dec 20 ; 304(4) G371 | DOI : 10.1152/ajpgi.00400.2012.
- MJ. Potthoff
References
Isolation and Characterization of exendin-4, an exendin-3 Analogue, From Heloderma Suspectum Venom. Further Evidence for an Exendin Receptor on Dispersed Acini From Guinea Pig Pancreas
JBC . 1992 Apr 15 ; 267(11) 7402 | DOI : PMID: 1313797
- J. Eng
- et al
Once Daily Injection of exendin-4 to Diabetic Mice Achieves Long-Term Beneficial Effects on Blood Glucose Concentrations
Diabetologia . 1999 Jan 01 ; 42 45 | DOI : 10.1007/s001250051111.
- NH. Greig
- et al
Exendin-4 Is a High Potency Agonist and Truncated exendin-(9-39)-amide an Antagonist at the Glucagon-Like Peptide 1-(7-36)-amide Receptor of Insulin-Secreting Beta-Cells
JBC . 1993 Sep 15 ; 268 19650 | DOI : PMID: 8396143
- R. Göke
- et al
High Potency Antagonists of the Pancreatic Glucagon-Like peptide-1 Receptor
JBC . 1997 Aug 22 ; 272 21201 | DOI : 10.1074/jbc.272.34.21201.
- C. Montrose-Rafizadeh
- et al